Venrock Healthcare Capital Partners III, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share (ELVN)

Filing Manager
Venrock Healthcare Capital Partners III, L.P.
Reporting Manager
Venrock Healthcare Capital Partners III, L.P.
Security
ENLIVEN THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
ELVN
Shares outstanding
59.7M shares
Disclosed Ownership
3.23M shares
Ownership
5.4%
Form type
SCHEDULE 13G/A
Date filed
11/14/2025, 05:32 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Venrock Healthcare Capital Partners III, L.P. 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P. 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
Nimish Shah 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact
Bong Y. Koh 5.4% 3.23M 0 3.23M /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact